Overview

Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a possible role of intravesical Hyaluronic Acid in reducing local toxicity of Bacillus Calmette Guerin (BCG) used to treat bladder urothelial cell carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
University of Rome Tor Vergata
Treatments:
BCG Vaccine
Hyaluronic Acid